Advanced Tissue Sciences finally gains FDA thumbs-up for Dermagraft
This article was originally published in Clinica
Executive Summary
Advanced Tissue Sciences (ATS) has at last gained US approval to sell its tissue-engineered skin substitute, Dermagraft, for treating diabetic foot ulcers.